A large body of evidence indicates that circulating inflammatory biomarkers, including interleukin (IL)-4, IL-6, IL-8, C-reactive protein (CRP), and tumor necrosis factor-α (TNF-α), may be associated with breast cancer risk [14,15,16]. Here, IL6 is linked to breast cancer.